Avantor expands bioproduction footprint into China

US-based Avantor has acquired RIM

Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. RIM

Bio’s Changzhou, China, facility is Avantor’s first single-use production plant in the Asia, Middle East and

Africa (AMEA) region, building on the company’s existing global single-use manufacturing network in the Americas and Europe and greatly increasing capacity to meet growing global demand in bioprocessing. Avantor will leverage RIM Bio’s proprietary technologies and best-in-class lead times to provide single-use customers with a differentiated offering. This acquisition marks another major investment in China. In December 2019, the company opened its Shanghai Innovation & Customer Support centre, a dedicated bioprocessing facility focused on research, application development and process optimization solutions for biopharma companies across AMEA.